Hodgkin爷s lymphoma (Hodgkin disease, HD) is a malignant disease of the lymphatic system. The treatment of Hodgkin爷s lymphoma has significantly progressed in recent decades with the combination of chemotherapy and radiotherapy. About 80% of patients are expected to cure after proper treatment. The research of prognosis in the patients with Hodgkin爷s lymphoma is also very mature. Several factors have been found to be associated with the prognosis of patients with earlystage (I + II) and advantagestage (III + IV) Hodgkin爷s lymphoma [13] . However, the prognostic value of hepatitis B virus (HBV) infection is unclear. A large number of studies have shown that HBV infection rate is higher in nonHodgkin爷s lymphoma patients than in normal population [4] , suggesting the existence of etiological association between HBV and nonHodgkin爷s lymphoma. But what is the incidence of HBV infection in Chinese patients with Hodgkin爷s lymphoma and how does the infection affect the survival of the patients? To address these questions, we retrospectively analyzed clinical data of 120 patients diagnosed with Hodgkin爷s lymphoma and treated at the Sun
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Clinical data
We collected and analyzed retrospectively clinical data of 120 patients who were diagnosed with Hodgkin爷s lymphoma and treated at the Sun Yatsen University Cancer Center between January 2004 and October 2007.
All patients included in the analysis met the following criteria: they were pathologically confirmed as Hodgkin爷s lymphoma and had detailed clinical and followup data; they took routine blood test at their first visits and thus had information of albumin level and erythrocyte sedimentation rate; they also took HBVM test (HBsAg, HBsAb, HBeAg, HBeAb, HBcAb (1) asymptomatic erythrocyte sedimentation rate 逸 50 mm/h, (2) 逸 3 lesions with symptom B, (3) 逸 2 lesions outside lymph, and (4) large lesions (any lesion with maximal diameter > 10 cm, or the ratio of the maximal diameter of mediastinal lesions to the maximal diameter of chest > 1/3). Risk factors for advanced Hodgkin爷s lymphoma were (1) albumin < 40 g/L, (2) hemoglobin < 105 g/L, (3) male, age 逸 45 years old, (4) stage IV, (5) leukocytosis (逸 15 伊 10 9 /L), and (6) decreased lymphocytes (lymphocyte ratio < 8% or absolute lymphocyte < 0.6 伊 10 9 /L) [3] . Patients were followed up by telephone or letter communication every three months after treatment. Till June 2009, these patients had a median followup time of 36.3 months (range, 3178 months).
Curative effect was categorized according to international response criteria for nonHodgkin爷s lymphoma as follows: CR, PR, stable disease (SD), and progressive disease (PD) [5] .
All statistical analyses were performed by Statistical Package of Social Sciences 13.0 software. A value of < 0.05 was considered to be statistically significant. The KaplanMeier method was used to estimate the 5year overall survival. For patients who remained alive, data were censored at the date of the last contact. The KaplanMeier analysis with a logrank testing was used for univariate analysis. Variables showing a trend for association with survival ( < 0.05) were selected in the final multivariate Cox proportional hazards model.
A total of 37 patients developed disease progression and 11 of them died. The 5year overall survival rate was 87.6% ( Figure 1 ), and 5year progressionfree survival rate was 50.2%. The 5鄄 year overall survival was 87.6% in the whole patients. The 5鄄 year overall survival of the HBsAg鄄 negative and 鄄 positive patients are 96.0豫 and 64.8豫, respectively, with significant difference (P < 0.001). Table 3 ).
We further divided the patients into two groups based on their clinical stages (early stage vs. advanced stage) and compared survival rate between HBsAgpositive and negative patients in these two groups individually. We found that 5year overall survival for HBsAgpositive patients were shorter than that for HBsAgnegative ones in earlystage groups, and the 5year overall survival rates for HBsAgpositive and negative patients were 64.8% and 96.0% , respectively ( < 0.001, Figure 2) . However, the difference of survival between HBsAgpositive and negative patients was not statistically significant in advancedstage group (75.0% vs. 84.8%, = 0.667).
Univariate analysis showed that PS score, the number of risk factors, HBsAg expression and age were prognostic factors for Hodgkin爷s lymphoma patients ( = 0.001, 0.002, 0.006, and 0.021, respectively); whereas gender, clinical stage, pathologic type, and radiotherapy were not prognostic factors ( = 0.647, 0.490, 0.087, and 0.060, respectively). Based on multivariate analysis, of gender, age, PS score, the number of risk factors, HBsAg expression, and radiotherapy, only the number of risk factors and HBsAg expression were independent prognostic factors for Hodgkin爷s lymphoma ( = 0.031 and 0.014, respectively).
Further analysis showed that PS score, the number of risk factors, HBsAg expression, age, and radiotherapy were prognostic factors for the patients with earlystage Hodgkin爷s lymphoma ( values were < 0.001, < 0.001, < 0.001, 0.03, and 0.012, respectively); whereas gender and chemotherapy methods were not ( = 0.265 and 0.886, respectively). In addition, multivariate analysis suggested that HBsAg infection and radiotherapy were independent factors affecting survival for the patients with earlystage Hodgkin爷s lymphoma ( = 0.014 and 0.006, respectively, Table 4 ).
The difference of diseasefree survival between HBsAg positive and negative patients were not statistically significant in the patients with early or advancedstage Hodgkin爷s lymphoma ( = 0.295 and 0.48, respectively). Furthermore, univariate analysis suggested that radiotherapy was the only prognostic factor for diseasefree survival ( < 0.001) and age, gender, PS score, clinical stage, pathologic type, number of risk factors, and HBsAg expression were not prognostic factors affecting diseasefree survival ( = 0.859, 0.670, 0.768, 0.463, 0.496, 0.384, and 0.174, respectively) . In this study, about 5.0% of patients belong to nodular lymphocytepredominant Hodgkin爷s lymphoma and 95.0% of them are classical Hodgkin's lymphoma. This proportion is similar to what have been reported in literature [6, 7] . HBV, first discovered in 1966, has more than 400 million infections globally by year 2000. China is a country of high hepatitis B incidence [8] , and more than 170 million Chinese are HBV carriers [9] . HBV infection plays important roles in the occurrence and development of primary liver cancer. Based on case reports in recent years, 30% of nonHodgkin爷s lymphoma patients were also HBsAgpositive [4, 10] , which was significantly higher than the HBV infection rate in normal population. Studies have also suggested that HBsAgpositive patients suffered from Bcell nonHodgkin爷s lymphoma at younger age than did HBsAg negative ones [4] , suggesting HBV infection plays a role in Bcell nonHodgkin爷s lymphoma etiology. However, HBV infection rate in patients with Hodgkin爷s lymphoma has been reported less. Our results showed that 15.0% of 120 Hodgkin爷s lymphoma patients were HBsAgpositive, which was similar to the reported rate in normal population and was significantly lower than that in Bcell nonHodgkin爷s lymphoma patients.
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Univariate and multivariate analyses suggested that HBsAg expression and the number of risk factors were independent prognostic factors affecting survival of the patients with Hodgkin爷s lymphoma. When we further divided patients into earlystage and advancedstage groups, HBsAg has major effect on survival in earlystage Hodgkin爷s lymphoma patients. In addition, HBsAg infection and radiotherapy were also independent prognostic factors for earlystage Hodgkin爷s lymphoma patients, but not for advancedstage Hodgkin爷s lymphoma patients. Although the survival of HBsAgpositive patients with nonHodgkin爷s lymphoma was not significantly different from that of HBsAg negative patients, it appeared that these patients had worse outcomes if they had compromised liver function [8, 9, 11] . NonHodgkin爷s lymphoma patients usually receive chemotherapy regimens containing immunosuppressive drugs and hormones. Such chemotherapy regimens, in particular the use of rituximab in CD20positive Bcell lymphoma, may induce humoral immune response. Rituximab is a monoclonal antibody against CD20 on B cells. Because B lymphocytes are antigenpresenting cells during the immune attack, rituximab decreased the effectiveness of antigen presentation thus exacerbating the attack of HBV [12] . In addition, chemotherapy is usually intermittent. During chemotherapy when immune system is suppressed, HBV replicate dramatically and the viral load increases. When chemotherapy stopped and immune function was restored, liver cells containing HBV might produce a strong immunemediated reaction leading to liver damage and severe outbreaks of hepatitis might occur [13, 14] . This explains why HBsAgpositive patients live shorter if they have compromised liver function. The present study is retrospective and the record of liver damage in the interim of chemotherapy is incomplete, therefore it is unclear if chemotherapy caused liver damage in the HBsAgpositive patients. However, none of our HBsAgpositive patients needed lower doses of chemotherapy drugs or extended intermittent chemotherapy because of adverse reactions. Further studies are thus needed to confirm that hepatic dysfunction accounts for differences in survival between the HBsAgpositive and negative patients.
Our study showed that HBV infection is not an independent prognostic factor affecting diseasefree survival for Hodgkin爷s lymphoma patients. In addition, gender, age, PS status, the number of risk factors, and chemotherapy do not affect diseasefree survival either, which is similar to what Lim . [15] reported. The reasons for poor survival of HBsAgpositive patients with earlystage Hodgkin爷s lymphoma warrant further study.
In addition, we found that the difference of survival between HBsAgpositive and negative patients is not statistically significant in advancedstage Hodgkin爷s lymphoma patients. Many patients with advanced Hodgkin爷s lymphoma have multiple risk factors. Organ damages caused by liver infiltration or other reasons affect survival than HBV. Therefore, it is not surprising that HBV is an independent prognostic factor for survival in earlystage Hodgkin爷s lymphoma patients, but not in advancedstage ones.
Finally, factors associated with the survival of earlystage Hodgkin爷s lymphoma patients are different from those associated with survival of overall Hodgkin爷s lymphoma patients. HBsAgpositive is a prognostic factor for bothgroups of patients. Whereas radiotherapy affects survival of earlystage Hodgkin爷s lymphoma patients, the number of risk factors has greater effect on survival of overall Hodgkin爷s lymphoma patients. This once again confirms several other studies that suggested radiotherapy is a prognostic factor affecting survival for the patients with earlystage Hodgkin爷s lymphoma. Herbst . [16] reported that the addition of radiotherapy on chemotherapy can improve disease control and overall survival in earlystage Hodgkin爷s lymphoma patients based on Meta analysis of prognosis in 1245 cases. NCCN guidelines also recommend the patients with stageIA to stage IIA HD should undergo local radiotherapy.
In summary, we found that HBV infection rate is similar between Hodgkin爷s lymphoma patients and normal population, but HBV infection is an independent prognostic factor affecting survival for earlystage patients according to both univariate and multivariate analyses. Further studies are required to understand the mechanisms and thus improve the survival of patients with Hodgkin爷s lymphoma.
